SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.33-8.6%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: xomadog2 who wrote (9958)5/14/1999 11:10:00 AM
From: Robert K.  Read Replies (1) of 17367
 
George, I have to agree with xomadog 100% here.>>>>>>>>>>>>>>>
>>>>"The expectation to have results given out to the shareholders is unrealistic. The company is "locked" in to a process of approval,that, to blab the results around without the consent of the FDA would be devastating. The company is not "allowed" based on an
established quid pro quo with the FDA to do anything about giving the news to shareholders first with regard to results of trials."

As such, I opened my annual report packages, totaled my shares
(to see what I had) and vote all yes's via internet. I did abstain on 25 shares though as a gesture. I dont really care for proposal #2, and am really wary of proposal #3 but the benefits probably do outway the risks. I do think management is good and acting in a generally responsible manner. If (big if) they get to market you should kiss their feet.
All IMO, standard K disclaimers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext